CD1 gene polymorphisms and phenotypic variability in X-linked adrenoleukodystrophy

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Barbier, Mathieu ^a   Sabbagh, Audrey ^a,c   Kasper, Edwige ^a   Asheuer, Muriel ^a   Ahouansou, Ornella ^a   Pribill, Ingrid ^b   Forss Petter, Sonja ^b   Vidaud, Michel ^a   Berger, Johannes ^b   Aubourg, Patrick ^a  

^a FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^b Medical University of Vienna   (Austria)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; CD1B ANTIGEN; CD1D ANTIGEN; CD1D PROTEIN, HUMAN; VERY LONG CHAIN FATTY ACID;

ADRENOLEUKODYSTROPHY; ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CD1 GENE; CD1A GENE; CD1B GENE; CD1C GENE; CD1D GENE; CD1E GENE; CHILD; CONTROLLED STUDY; DNA SEQUENCE; GENE; GENE LOCATION; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC VARIABILITY; GENETICS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHENOTYPE; PHENOTYPIC VARIATION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADRENOLEUKODYSTROPHY; ALLELES; ANTIGENS, CD1; ANTIGENS, CD1D; BASE SEQUENCE; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENETICS; HUMANS; MIDDLE AGED; PATHOLOGY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 84855793882     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029872     Document Type: Article

References (22)

1. Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, et al. (1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361: 726-730.
2. van Roermund CW, Visser WF, Ijlst L, van Cruchten A, Boek M, et al. (2008) The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters. FASEB J 22: 4201-4208.
3. Moser HW, Smith KD, Watkins PA, Powers J, Moser A, (2001) The Metabolic and Molecular Bases of Inherited Disease. pp. 3257-3301 The Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill, New-York.
4. Berger J, Gartner J, (2006) X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects. Biochim Biophys Acta 1763: 1721-1732.
5. Kemp S, Pujol A, Waterham HR, van Geel BM, Boehm CD, et al. (2001) ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Hum Mutat 18: 499-515.
6. Ferrer I, Aubourg P, Pujol A, (2010) General aspects and neuropathology of X-linked adrenoleukodystrophy. Brain Pathol 20: 817-830.
7. Ito M, Blumberg BM, Mock DJ, Goodman AD, Moser AB, et al. (2001) Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation. J Neuropathol Exp Neurol 60: 1004-1019.
8. Maestri NE, Beaty TH, (1992) Predictions of a 2-locus model for disease heterogeneity: application to adrenoleukodystrophy. Am J Med Genet 44: 576-582.
9. Kemp S, Wanders R, (2010) Biochemical aspects of X-linked adrenoleukodystrophy. Brain Pathol 20: 831-837.
10. Barral DC, Brenner MB, (2007) CD1 antigen presentation: how it works. Nat Rev Immunol 7: 929-941.
11. Novak J, Lehuen A, (2011) Mechanism of regulation of autoimmunity by iNKT cells. Cytokine 53: 263-270.
12. Porcelli SA, (1995) The CD1 family: a third lineage of antigen-presenting molecules. Adv Immunol 59: 1-98.
13. Bricard G, Porcelli SA, (2007) Antigen presentation by CD1 molecules and the generation of lipid-specific T cell immunity. Cell Mol Life Sci 64: 1824-1840.
14. Cheng TY, Relloso M, Van Rhijn I, Young DC, Besra GS, et al. (2006) Role of lipid trimming and CD1 groove size in cellular antigen presentation. EMBO J 25: 2989-2999.
15. Gautron AS, Giquel B, Beaudoin L, Autrusseau E, Speak A, et al. (2010) Invariant NKT cells in adrenoleukodystrophy patients and mice. J Neuroimmunol 229: 204-211.
16. Linnebank M, Kemp S, Wanders RJ, Kleijer WJ, van der Sterre ML, et al. (2006) Methionine metabolism and phenotypic variability in X-linked adrenoleukodystrophy. Neurology 66: 442-443.
17. Matsukawa T, Asheuer M, Takahashi Y, Goto J, Suzuki Y, et al. (2010) Identification of novel SNPs of ABCD1, ABCD2, ABCD3, and ABCD4 genes in patients with X-linked adrenoleukodystrophy (ALD) based on comprehensive resequencing and association studies with ALD phenotypes. Neurogenetics 12 (1): 41-50.
18. Bodmer W, Bonilla C, (2008) Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 40: 695-701.
19. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
20. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
21. Li J, Ji L, (2005) Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95: 221-227.
22. Nyholt DR, (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74: 765-769.